Formulary guidance and transparency from P&T to point of care

MMIT Reality Check on Narcotic Pain (Sep 2017)

Posted by Matt Breese on Sep 11, 2017

Find me on:

According to our recent payer coverage analysis for narcotic pain treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Payer Coverage: A market access snapshot for narcotic pain treatments shows an increase in the percentage of average restricted lives. The percentage of covered lives with PAs and step edits also increased significantly.


Source: MMIT data as of Q3 2017

Trends:  CDC guidelines from last year continue to drive shifts in the way prescribers prescribe and the way in which patients adhere to treatment plans. Development for this disease area is led by innovative, abuse-deterrent products.

To read the full Reality Check on narcotic pain treatments with key findings on clinical characteristics, narcotic pain drug market access and payer coverage, please click on the button below: 


View Reality Check


Topics: Specialty, Market Access, Branding & Marketing